CHARACTERIZING PRACTICE PATTERNS IN DISEASE ACTIVITY MONITORING OF INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWING BIOLOGIC INITIATION WITHIN A LARGE REGIONAL HEALTHCARE SYSTEM

被引：0
|
作者：
Stanton, Matthew B.
Basra, Saihej P.
Hanauer, Stephen B.
Dulai, Parambir S.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1784
引用
收藏
页码：S521 / S522
页数：2
相关论文
共 50 条
  • [21] Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy
    Anand Kumar
    Vinayak Shenoy
    Megan C. Buckley
    Laura Durbin
    James Mackey
    Anjali Mone
    Arun Swaminath
    Digestive Diseases and Sciences, 2022, 67 : 4851 - 4865
  • [22] The Impact of Delay Between Biologic Prescription and Therapy Initiation on Clinical Outcomes in Inflammatory Bowel Disease Patients
    Agrawal, Manasi
    Tepler, Adam
    Hong, Simon
    Advani, Rashmi
    Lukin, Dana
    GASTROENTEROLOGY, 2019, 157 (01) : E23 - E23
  • [23] Prescriber Practice Patterns in Non-compliant Patients with Inflammatory Bowel Disease
    Bernstein, Gregory R.
    Rothstein, Robin D.
    Friedenberg, Frank K.
    Ehrlich, Adam C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S309 - S310
  • [24] Individualised home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended implemented in clinical practice
    Ankersen, D. V.
    Marker, D.
    Weimers, P.
    Burisch, J.
    Munkholm, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S52 - S53
  • [25] Biologic Therapy and Therapeutic Drug Monitoring in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
    Varun, Jain
    Brian, Behm
    Esteban, Figueroa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S5 - S5
  • [26] A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients' and physicians' preferences and adherence
    Christensen, Katrine Risager
    Steenholdt, Casper
    Buhl, Sine
    Brynskov, Jorn
    Ainsworth, Mark Andrew
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (03) : 274 - 281
  • [27] Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease
    Shah, Nisha B.
    Zuckerman, Autumn D.
    Hosteng, Katie R.
    Fann, Jessica
    Declercq, Josh
    Choi, Leena
    Cherry, Laura
    Schwartz, David A.
    Horst, Sara
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (12) : 4331 - 4338
  • [28] Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease
    Nisha B. Shah
    Autumn D. Zuckerman
    Katie R. Hosteng
    Jessica Fann
    Josh DeClercq
    Leena Choi
    Laura Cherry
    David A. Schwartz
    Sara Horst
    Digestive Diseases and Sciences, 2023, 68 : 4331 - 4338
  • [29] Healthcare utilisation patterns and drivers amongst inflammatory bowel disease patients in the outpatient clinic
    Koppelman, Lola J. M.
    Maljaars, P. W. Jeroen
    Voorneveld, Philip W.
    van der Meulen-de Jong, Andrea E.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 37 (02) : 176 - 183
  • [30] Vedolizumab Decreases Utilization of Healthcare Resources in Biologic-naive Inflammatory Bowel Disease (IBD) Patients
    Kassim, Olufemi
    Micic, Dejan
    Christensen, Britt
    Lissoos, Trevor
    Luo, Michelle
    Null, Kyle D.
    Cohen, Russell
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S334 - S335
12345